Embracing Transformation

- by Dr. Sean Costello (Director, Innopharma Technology)

Last week at the Pharma 4.0 event in Dublin, I had the pleasure of listening to speaker Henrik Von Scheel, renowned as the ‘Father of Industry 4.0’ and the mastermind of the EU Digital Agenda. As a leading authority on strategy and competitiveness for industry and government alike, Henrik provided unparalleled insight into how Industry 4.0 represents, “the fusion of the physical, digital, and virtual worlds, set against a backdrop of 17 colliding trends ranging from AI to Neurotechnology”.

Henrik is highly respected in the boardrooms even though his message can, at times, seem contrarian to conventional thinking. But this is because he brings meaningful clarity to noise and encourages the need to apply different thinking and toolsets.

Manufacturers need to rethink the entire value chain. There are only six different ways to model your manufacturing operations: revenue, value, cost, performance, service, and operating model.

- Henrik Von Scheel

His talk was great as he described conceptually how Industry 4.0 would deliver opportunities for growth and innovation, reset the competitive landscape, rethink new service models and redefine the next leap in productivity that transforms operational excellence. However, Henrik did have a word of warning that because 4.0 is disruptive if you don’t change, you won’t survive. Henrik described how 4.0 is coming in waves and that the longer you leave embracing transformation, then the harder it will be to stay competitive. Having worked in both start-up, medium, and multinational enterprises, I know how hard this is when corporates are cost-competitive. “Normally businesses have three to five years to react to changes in their industry,” according to Henrik.

But when you have so many simultaneous changes occurring, it becomes disruptive, and your ability to react becomes more difficult. This is called the ‘change gap.’ If you are fighting on too many fronts, then you lose the fight.

- HV Scheel

How valuable is this message for Pharma 4.0?

I felt, the key goal of Henrik’s task was to drive home the message that Industry 4.0 changing at a rate and pace never seen previously. He provided several compelling proof points to this effect. To contend with such constant change, Henrik’s big advice was to master the discipline of ‘innovation’ (i.e. developing your business) and ‘transformation’ (i.e., running your business), and to “think functionally, act strategically.”

For Pharma 4.0, this is all about the transformation of cyber-physical production systems to connect the physical and digital world of production, creating a more flexible, resource-efficient, customised way of manufacturing. It is the ‘Smart Factory’ which leverages the Internet of things (IoT) and where the integrated analysis of data and collaboration forms critical value drivers. 

There is evidence of such concepts already manifesting in the real world as different parts of the pharma value chain start to embrace AI and other 4.0 technologies. At Innopharma Technology, we have embraced the 4.0 revolution; by connecting process equipment and sensors using IoT approach to enable cloud-based analytics, self-guided process control, and Smart workflows for accelerated process development. I am looking forward to being a part of making this space grow. 

I recall Henrik's parting words of encouragement. There is absolutely nothing to fear from these technological changes because people will always be at the center of technology.  As he put more strongly......

People are a summary of competencies – and competencies are dependent on investing in skills. People are the means by which businesses adapt to the changes represented by Industry 4.0.

- HV Scheel

Claude Lacey

Claude Lacey leads the Innopharma Technology software development team and has worked in software development for over 20 years.  Prior experience includes software development management in the medical device industry where he led the development of digital pathology software applications.  His areas of expertise include cloud architecture, imaging and data driven systems, UX design, agile and lean thinking.  He has a special interest in IoT, machine learning and computer graphics technologies. Claude holds a BSc in Computer Science and PgDip in Pharmaceutical Business and Technology.

Girish Mallya

Girish Mallya is a Senior Software Developer working at Innopharma Technology with 12 years of professional experience developing image analysis solutions and is responsible for the technical aspects of software R&D projects that involve image analysis/computer vision. Apart from image processing and computer vision, he has experience in C++, Python, MATLAB, Machine learning for image analysis.

Volodymyr Rudiakov

Volodymyr Rudiakov is a Senior Software Developer at Innopharma Technology with 8 years of experience of using C++, Python, JavaScript, NodeJS, Java and different technologies for data exchange, storage and processing, IoT devices and systems integration, and process automation. Overall, more than 20 years of networks specialist and systems integrator experience.

Real Time Data Insights

SmartXTM eases the burden of full and proper implementation of Quality by Design (QBD) principles, by giving teams access to error-free, good manufacturing data from all stages of the development process.

Our Products

SmartX - Accelerated development and advanced manufacturing platform for Fluid Bed Systems.

Read more  

Multieye2 - Multipoint, near infrared spectrophotometer for measuring changes in process.

Read more  

Eyecon2 - Market-leading particle analyser for powders and bulk solids. 

Read more  
Pharma Awards 2019